Damon Runyon 2018 Clinical Research Award

The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. 

Funding: 

• $600,000 over three years ($200,000 per year).
• Funding begins July 1, 2019
• Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research.
• No part of this grant can be used for indirect costs or institutional overhead; however this award is listed on Exhibit A.
• Investigators may receive funding from other sources to support their research.  However, no other physician-scientist mentored career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award.
• Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
• Scientific or budgetary overlap with other funded projects is not allowed. 
• Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):

• AACR- Career Development Award
• American Cancer Society- Mentored Research Scholar Grants in Applied and Clinical Research
• ASCO- Career Development Award
• Burroughs Wellcome Fund- Career Award for Medical Scientists
• Doris Duke Charitable Foundation- Clinical Scientist Development Award
• Howard Hughes Medical Institute- Physician-Scientists Early Career Award, Early Career Scientist Competition
• Leukemia and Lymphoma Society- Career Development Program, Scholar Awards

Eligibility Requirements

Eligibility:

• The applicant must be a U.S. citizen or permanent legal resident.
• The applicant must hold a valid, active U.S. medical license at the time of application.
• The applicant must apply within the first four (4) years of his/her initial full faculty appointment (cut-off July 2015). Adjunct or acting positions are not eligible.
• Candidates holding or awarded R01s at the time of application are not eligible to apply.
• The applicant must commit to spending 80% of their time conducting research.
• The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award.  No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.

Application Instructions

Please submit:

1. a one-page letter of intent with a description of proposed aims and approach
2. Biosketch or CV of the PI
3. A letter of support from the Dean or Chair. This letter of support signifies that the Dean or Chair have ensured that the nominee and application are likely to be of sufficient quality to be competitive nationally

to research@uw.edu by 5:00 PM Thursday December 6, 2018. The UW limited submissions review committee will review and rank pre-proposals, then send the rankings to the Fred Hutch review committee for final decisions. Proposals are due to the sponsor 1/24/19, so you will need to have your materials in to the Office of Sponsored Programs by 2/1/19 for processing, if given the go ahead by the Proposal Review Committee.